EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need

Daan de Jonge, Pim B van der Meer, Cornelis Kramers, Arnt Schellekens

Current Psychiatry Reports · 2024-12 · 26 (12) · 832-842

DOI: 10.1007/s11920-024-01567-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Psychiatry Reports, online erschienen am 29.11.2024. Verfasst von Daan de Jonge und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology-Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Alcoholism, Major Depressive Disorder, Hallucinogens, Psilocybin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 98 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF REVIEW: In this narrative review, we discuss evidence for psilocybin- and LSD-assisted treatment of alcohol use disorder (AUD) and major depressive disorder (MDD). We describe limitations of psychedelic research and posit methodological considerations when designing a trial in patients with both disorders. RECENT FINDINGS: In AUD, a growing evidence base for psilocybin treatment shows a promising beneficial and sustained effect on measures of drinking frequency. In MDD, a recent meta-analysis has demonstrated that psilocybin therapy provides a large and consistent reduction in depressive symptoms compared to no treatment. Co-occurrence of MDD and AUD is quite prevalent, and this comorbidity exacerbates symptomatology of the two individual disorders and complicates their treatment. Theoretically, patients presenting with both AUD and MDD would benefit from an integrated therapy that could treat MDD and AUD simultaneously. We believe that more research into the efficacy of psilocybin in patients with both AUD and MDD is warranted and justified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlcoholismMajor Depressive DisorderHallucinogensPsilocybinHumansComorbidityLysergic Acid Diethylamide

Stichwörter der Autor:innen

Alcohol use disorderLysergic acid diethylamideMajor depressive disorderPsilocybinSubstance use disorderTreatment-resistant depression

Substanzen

HallucinogensLysergic Acid DiethylamidePsilocybin

Autor:innen und Institutionen

  • Department of Pharmacology-Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands. pbvandermeer@lumc.nl.
  • Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.

Zitieren

APA

de Jonge, D., van der Meer, P. B., Kramers, C., & Schellekens, A. (2024). Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need. Current Psychiatry Reports, 26(12), 832-842. https://doi.org/10.1007/s11920-024-01567-4

Vancouver

de Jonge D, van der Meer PB, Kramers C, Schellekens A. Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need. Current Psychiatry Reports. 2024;26(12):832-842. doi:10.1007/s11920-024-01567-4

BibTeX
@article{deJonge2024,
  author = {de Jonge, Daan and van der Meer, Pim B and Kramers, Cornelis and Schellekens, Arnt},
  title = {Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need},
  journal = {Current Psychiatry Reports},
  year = {2024},
  volume = {26},
  number = {12},
  pages = {832--842},
  doi = {10.1007/s11920-024-01567-4}
}
Kostenlos starten →